Search clinical trials for: FCN-437c Fulvestrant

Total 1013 results

Ahon Pharmaceutical Co., Ltd.

Completed

Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Advanced Breast Cancer

China
Ahon Pharmaceutical Co., Ltd.
Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaborators

Recruiting

Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin

Breast Neoplasms

China
Fochon Pharmaceuticals, Ltd.

Completed

Study of FCN-437c in Patients With Advanced Solid Tumors (FCN-437c)

Solid Tumor, Adult

United States
Ahon Pharmaceutical Co., Ltd.

Recruiting

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Advanced Breast Cancer | Female Breast Cancer

China
Fochon Pharmaceuticals, Ltd.

Recruiting

Study of FCN-011 in Patients With Advanced Solid Tumor（Phase I）and NTRK Fusion Positive Advanced Solid Tumor （Phase II）

Advanced Solid Tumor

China
Shanghai Fosun Pharmaceutical Industrial Development...

Recruiting

To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH

Langerhans Cell Histiocytosis | LCH

China
Fochon Pharmaceuticals, Ltd.

Recruiting

Study of FCN-098 in Patients With Advanced Solid Tumor

Solid Tumor

China
Fochon Pharmaceuticals, Ltd.

Recruiting

A Study of FCN-338 in Patients With Chronic CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

China
Shanghai Fosun Pharmaceutical Industrial Development...

Suspended

MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)

Melanoma

China
Ahon Pharmaceutical Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown

A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation

Lung Cancer

China
Shanghai Fosun Pharmaceutical Industrial Development...

Active, not recruiting

Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1

Neurofibromatosis 1 | NF1 | Plexiform Neurofibroma

United States, China, Spain
Ahon Pharmaceutical Co., Ltd.
Zhejiang Cancer Hospital; Fudan University; Sir Run Run Shaw Hospital

Unknown

Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

Breast Neoplasms

China
Ahon Pharmaceutical Co., Ltd.

Recruiting

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Advanced Breast Cancer | Female Breast Cancer

China
Genor Biopharma Co., Ltd.

Recruiting

GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

Locally Advanced or Metastatic Breast Cancer

China
Ontario Clinical Oncology Group (OCOG)
AstraZeneca

Completed

Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer (ZAMBONEY)

Metastatic Breast Cancer

Canada
Rutgers, The State University of New Jersey

Recruiting

Refinements of Functional Communication Training

Aggression | Self-injurious Behavior

United States
Xuanzhu Biopharmaceutical Co., Ltd.

Recruiting

A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer

Advanced Breast Cancer

China
Mashhad University of Medical Sciences
Grudzen, Corita, M.D., MSHS

Unknown

Effects of Fun Physical Activity on the Interest to Daily Physical Activity and Sarcopenia of Elderly People

Activity

Iran, Islamic Republic of
CONRAD
United States Agency for International Development (USAID); PATH

Completed

Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom (CONRAD-108)

Birth Control

United States
Matthew J O'Brien, PhD, BCBA-D
National Institute of Mental Health (NIMH); Emory University; University of Houston and other collaborators

Completed

Comparing Behavioral Assessments Using Telehealth for Children With Autism

Autism Spectrum Disorder

United States
Montreal Heart Institute
National Health and Medical Research Council, Australia

Completed

Identifying Strategies to Alleviate Cardiovascular Stress in Coronary Patients During Heatwaves

Coronary Artery Disease

Canada
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer

Breast Cancer

China
Castle Creek Biosciences, LLC.

Active, not recruiting

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (DEFI-RDEB)

Recessive Dystrophic Epidermolysis Bullosa

United States
University of Texas Southwestern Medical Center

Recruiting

Heat Waves and the Elderly - Cooling Modalities

Hyperthermia | Aging

United States
Yale University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Impact of Family-Centered Care for Intimate Partner Violence (IPV)

Intimate Partner Violence

United States
Fundació Sant Joan de Déu

Active, not recruiting

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma (RTB)

Retinoblastoma, Recurrent

Spain
Tan Tock Seng Hospital

Completed

Experience and Technology Acceptance of Older Adults Towards a Gamified Rehabilitative Device Prototype

Knee Osteoarthritis

Singapore
Diakonhjemmet Hospital

Completed

The Musculocutaneous Nerve in a High Resolution MRI

Brachial Plexus Block

Norway
Biogen

Terminated

Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

France, United States, Belgium, Australia, Austria, Poland, Canada, United Kingdom
Roswell Park Cancer Institute

Completed

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Prostate Cancer

United States
Marc Breton
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery (Rocket-BPS)

Type 1 Diabetes

United States
Fudan University

Active, not recruiting

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Metastatic Breast Cancer

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

ICI 182780 in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States, Canada
Sun Yat-sen University
AstraZeneca

Unknown

Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer (FANCY)

Breast Cancer

China
Hadassah Medical Organization

Completed

Effectiveness of a Cognitive-functional (Cog-Fun) Intervention for Children With ADHD

ADHD

Israel
University of Oregon
National Institute on Drug Abuse (NIDA)

Completed

Prevention of Substance Use in At-Risk Students: A Family-Centered Web Program

Depression | Anxiety | Substance Use | Conduct Disorders in Adolescence

United States
Biogen

Terminated

Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) (LUCID)

Chronic Lymphocytic Leukemia

United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Lithuania, Poland, Romania, Australia, Argentina, Austria, Canada, France, Israel, New Zealand, Portugal, Slovakia, Greece, Germany, India, Bel...
Zhejiang Cancer Hospital

Recruiting

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Breast Neoplasm Female

China
European Organisation for Research and Treatment...
Breast International Group

Terminated

ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer

Breast Cancer

United Kingdom
Nanjing Chia-tai Tianqing Pharmaceutical

Recruiting

A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer

HR Positive/HER-2 Negative Breast Cancer

China
Liaoning Tumor Hospital & Institute

Not yet recruiting

Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors

Breast Cancer
The First Affiliated Hospital of Zhengzhou University

Recruiting

An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

Breast Cancer | Breast Cancer Female

China
Novartis Pharmaceuticals

Recruiting

Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world (SPEAR)

Breast Cancer

India
Sun Yat-sen University

Recruiting

Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation

Breast Cancer

China
UNICANCER

Terminated

SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer (SAFIR-PI3K)

Breast Cancer, PI3K, Alpelisib

France
China Medical University Hospital

Recruiting

The Evaluation for Fu's Subcutaneous Needling (FSN) in Carpal Tunnel Syndrome.

Carpal Tunnel Syndrome

Taiwan
Mersin University

Completed

The Effect of Family-centered Care Educational Training on Nurses' Attitudes and Parental Satisfaction

Nursing Care

Turkey
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes

Stress | Complications | Breastfeeding | Bottle Feeding | Family Relationship

United States
University of Ottawa

Completed

Efficacy of Electric Fans for Mitigating Thermal Strain in Older Adults During Heat Waves

Hyperthermia | Aging | Heat Stress | Weather; Heat

Canada
M.D. Anderson Cancer Center
Bayer

Active, not recruiting

Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations

Ovarian Cancer | Endometrial Cancer

United States

3

Subscribe